Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks.
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks.
  • Published Date:

    Jun 1998

  • Source:
    Public Health Rep. 113(Suppl 1):151-159
  • Language:
    English
Filetype[PDF-2.59 MB]


Details:
  • Alternative Title:
    Public Health Rep
  • Personal Author:
    Latkin, C A
  • Description:
    Guided by a social influence and empowerment framework, peer leaders in the injecting drug user (IDU) community were trained to promote human immunodeficiency virus (HIV) prevention among their contacts within and beyond their sex and drug networks.|From 1994 to 1995 in Baltimore, Maryland, 36 peer leaders who participated in the 10-session training program were administered pretest and posttest surveys. Evaluation included leaders' self-reported HIV-related behaviors and outreach activities. Survey data also were collected from 78 of the leaders' risk network members.|Peer leaders reported a significant increase in condom use and in cleaning used needles with bleach. The leaders' risk network members, compared with controls, were significantly more likely to report greater needle hygiene. In an assessment of diffusion of information, the majority of risk network members who were current injectors reported receiving needle-cleaning materials from the leaders, and the majority of risk network members were able to correctly identify the HIV prevention slogans that had been taught to the leaders. The leaders documented 2165 HIV prevention interactions, of which 84% were with active drug users.|The results from this study suggest that, in the IDU community, training peer leaders as HIV educators may promote HIV prevention among the leaders' risk network members and others at risk of acquiring and transmitting HIV. This training also may provide the leaders with effective prosocial roles.
  • Subject:
  • Pubmed ID:
    9722820
  • Pubmed Central ID:
    PMCnull
  • Document Type:
    Journal Article
  • Funding:
  • Collection(s):
    Public Health Reports
  • Main Document Checksum:
  • File Type:
  • Supporting Files:
    No Additional Files
    1. Filetype[PDF - 135.73 KB]
      Published Date:
      6-1998
      Source:
      Public Health Rep. 113(Suppl 1)
      Description:
      The National Institute on Drug Abuse (NIDA), in collaboration with the Office of AIDS Research of the National Institutes of Health, invited national and international researchers to the "Research Synthesis Symposium on the Prevention of HIV in Drug ...
      File Type:
      Filetype[PDF - 135.73 KB]
    2. Filetype[PDF - 1.18 MB]
      Published Date:
      6-1998
      Source:
      Public Health Rep. 113(Suppl 1)
      Description:
      HIV prevention with drug-using populations : current status and future prospects
      File Type:
      Filetype[PDF - 1.18 MB]
    3. Filetype[PDF - 7.12 MB]
      Personal Author:
      Cottler, L B; Compton, W M; Ben Abdallah, A; Cunningham-Williams, R; Abram, F; Fichtenbaum, C; Dotson, W;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):31-41
      Description:
      The purpose of this chapter is to describe the results of a randomized study (funded by the National Institute on Drug Abuse [NIDA]) comparing a peer-delivered enhanced intervention to the NIDA standard intervention for reducing human immunodeficienc...
      File Type:
      Filetype[PDF - 7.12 MB]
    4. Filetype[PDF - 3.90 MB]
      Personal Author:
      Needle, R H; Coyle, S L; Normand, J; Lambert, E; Cesari, H;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):4-18
      File Type:
      Filetype[PDF - 3.90 MB]
    5. Filetype[PDF - 3.39 MB]
      Personal Author:
      Brooner, R; Kidorf, M; King, V; Beilenson, P; Svikis, D; Vlahov, D;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):129-139
      Description:
      Although lowering incidence rates of human immunodeficiency virus (HIV) transmission is the primary goal of needle exchange programs (NEPs), other desirable outcomes are possible. Referring exchange participants to more comprehensive drug abuse treat...
      File Type:
      Filetype[PDF - 3.39 MB]
    6. Filetype[PDF - 2.32 MB]
      Personal Author:
      Valente, T W; Foreman, R K; Junge, B; Vlahov, D;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):90-96
      Description:
      Our first objective was to develop an index of satellite exchange and then determine whether satellite exchangers (SEs) differed demographically or behaviorally from other injecting drug users (IDUs). Our second objective was to determine the degree ...
      File Type:
      Filetype[PDF - 2.32 MB]
    7. Filetype[PDF - 2.54 MB]
      Personal Author:
      Singer, M; Baer, H A; Scott, G; Horowitz, S; Weinstein, B;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):81-89
      Description:
      To break the link between drug use and the human immunodeficiency virus (HIV), in 1992 the state of Connecticut rescinded a 14-year ban on pharmacy sales of syringes without a physician's prescription. In 1993, the Center for Disease Control and Prev...
      File Type:
      Filetype[PDF - 2.54 MB]
    8. Filetype[PDF - 2.07 MB]
      Personal Author:
      Ball, A L; Rana, S; Dehne, K L;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):170-181
      Description:
      Human immunodeficiency virus (HIV) infection associated with injecting drug use has been reported in at least 98 countries and territories worldwide. There is evidence that new epidemics are emerging in different regions, including Eastern Europe, La...
      File Type:
      Filetype[PDF - 2.07 MB]
    9. Filetype[PDF - 5.34 MB]
      Personal Author:
      Coyle, S L; Needle, R H; Normand, J;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):19-30
      Description:
      Over the past decade, a body of observational research has accrued about the effects of outreach-based human immunodeficiency virus (HIV) interventions for drug users. The authors reviewed the findings related to postintervention behavior changes and...
      File Type:
      Filetype[PDF - 5.34 MB]
    10. Filetype[PDF - 2.15 MB]
      Personal Author:
      Levy, J A; Fox, S E;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):160-169
      Description:
      This analysis describes the Outreach-Assisted Model of Partner Notification, an innovative strategy for encouraging seropositive injecting drug users (IDUs) to inform their partners of shared human immunodeficiency virus (HIV) exposure. The analysis ...
      File Type:
      Filetype[PDF - 2.15 MB]
    11. Filetype[PDF - 230.08 KB]
      Published Date:
      6-1998
      Source:
      Public Health Rep. 113(Suppl 1)
      File Type:
      Filetype[PDF - 230.08 KB]
    12. Filetype[PDF - 2.90 MB]
      Personal Author:
      Booth, R E; Kwiatkowski, C; Iguchi, M Y; Pinto, F; John, D;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):116-128
      Description:
      High risk injection practices are common among injecting drug users (IDUs), even following intervention efforts. Moreover, relapse to risk behaviors has been reported among those who initiate risk reduction. Substance abuse treatment offers the poten...
      File Type:
      Filetype[PDF - 2.90 MB]
    13. Filetype[PDF - 3.45 MB]
      Personal Author:
      Kumar, M S; Mudaliar, S; Daniels, D;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):58-66
      Description:
      Community-based outreach to drug injectors is an important component of human immunodeficiency virus (HIV) prevention strategy. The purpose of this chapter is to evaluate the effectiveness of community-based outreach HIV intervention that has been im...
      File Type:
      Filetype[PDF - 3.45 MB]
    14. Filetype[PDF - 1.90 MB]
      Personal Author:
      Vlahov, D; Junge, B;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):75-80
      Description:
      Injecting drug users (IDUs) are at high risk for infection by human immunodeficiency virus (HIV) and other blood-borne pathogens. In the United States, IDUs account for nearly one-third of the cases of acquired immunodeficiency syndrome (AIDS), eithe...
      File Type:
      Filetype[PDF - 1.90 MB]
    15. Filetype[PDF - 780.81 KB]
      Personal Author:
      Shriver, M; de Burger, R; Brown, C; Simpson, H L; Meyerson, B;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):189-193
      Description:
      Five policy advocates and practitioners provide recommendations to researchers to make research data more usable, accessible, and applicable for the field of human immunodeficiency virus (HIV) prevention among injecting and other drug users. Translat...
      File Type:
      Filetype[PDF - 780.81 KB]
    16. Filetype[PDF - 413.01 KB]
      Personal Author:
      Leshner, A I
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):1-3
      File Type:
      Filetype[PDF - 413.01 KB]
    17. Filetype[PDF - 3.06 MB]
      Personal Author:
      Metzger, D S; Navaline, H; Woody, G E;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):97-106
      Description:
      As the acquired immunodeficiency syndrome (AIDS) epidemic among drug users enters its third decade in the United States, it is important to consider the role playing by substance abuse treatment in the prevention of human immunodeficiency virus (HIV)...
      File Type:
      Filetype[PDF - 3.06 MB]
    18. Filetype[PDF - 1.57 MB]
      Personal Author:
      Heimer, R
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):67-74
      Description:
      This chapter attempts to describe the factors influencing the transmission of syringe-born viruses, to review the effects of syringe exchange programs (SEPs) in terms of these factors, and to explore the gamut of health-promoting activities of SEPs.|...
      File Type:
      Filetype[PDF - 1.57 MB]
    19. Filetype[PDF - 2.89 MB]
      Personal Author:
      Neaigus, A
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):140-150
      Description:
      To review human immunodeficiency virus (HIV) risk reduction interventions among injecting drug users (IDUs) that have adopted a network approach.|The design and outcomes of selected network-based interventions among IDUs are reviewed using the networ...
      File Type:
      Filetype[PDF - 2.89 MB]
    20. Filetype[PDF - 3.12 MB]
      Personal Author:
      Hartel, D M; Schoenbaum, E E;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):107-115
      Description:
      We undertook a study of the role of methadone maintenance in protecting injecting drug users (IDUs) from human immunodeficiency virus (HIV) infection from the earliest days of the HIV epidemic in New York City to the present. The historical context o...
      File Type:
      Filetype[PDF - 3.12 MB]

You May Also Like:

  1. Filetype[PDF - 6.22 MB]
    Personal Author:
    Broadhead, R S; Heckathorn, D D; Weakliem, D L; Anthony, D L; Madray, H; Mills, R J; Hughes, J;
    Published Date:
    Jun 1998
    Source:
    Public Health Rep. 113(Suppl 1):42-57
    Description:
    Since 1985, community outreach efforts to combat acquired immunodeficiency syndrome (AIDS) among injecting drug users (IDUs) in the United States have overwhelmingly depended on a provider-client model that relies on staffs of professional outreach w...
    File Type:
    Filetype[PDF - 6.22 MB]
  2. Filetype[PDF - 2.15 MB]
    Personal Author:
    Levy, J A; Fox, S E;
    Published Date:
    Jun 1998
    Source:
    Public Health Rep. 113(Suppl 1):160-169
    Description:
    This analysis describes the Outreach-Assisted Model of Partner Notification, an innovative strategy for encouraging seropositive injecting drug users (IDUs) to inform their partners of shared human immunodeficiency virus (HIV) exposure. The analysis ...
    File Type:
    Filetype[PDF - 2.15 MB]
  3. Filetype[PDF - 2.89 MB]
    Personal Author:
    Neaigus, A
    Published Date:
    Jun 1998
    Source:
    Public Health Rep. 113(Suppl 1):140-150
    Description:
    To review human immunodeficiency virus (HIV) risk reduction interventions among injecting drug users (IDUs) that have adopted a network approach.|The design and outcomes of selected network-based interventions among IDUs are reviewed using the networ...
    File Type:
    Filetype[PDF - 2.89 MB]
  4. Filetype[PDF - 3.45 MB]
    Personal Author:
    Kumar, M S; Mudaliar, S; Daniels, D;
    Published Date:
    Jun 1998
    Source:
    Public Health Rep. 113(Suppl 1):58-66
    Description:
    Community-based outreach to drug injectors is an important component of human immunodeficiency virus (HIV) prevention strategy. The purpose of this chapter is to evaluate the effectiveness of community-based outreach HIV intervention that has been im...
    File Type:
    Filetype[PDF - 3.45 MB]
  5. Filetype[PDF - 3.06 MB]
    Personal Author:
    Metzger, D S; Navaline, H; Woody, G E;
    Published Date:
    Jun 1998
    Source:
    Public Health Rep. 113(Suppl 1):97-106
    Description:
    As the acquired immunodeficiency syndrome (AIDS) epidemic among drug users enters its third decade in the United States, it is important to consider the role playing by substance abuse treatment in the prevention of human immunodeficiency virus (HIV)...
    File Type:
    Filetype[PDF - 3.06 MB]